Venrock Healthcare Capital Partners III, L.P.

13D and 13G Filings

13D/G filings: 13D on 2 securities, 13G on 44 securities
Location: New York, NY
CIK: 0001738048
Form D filings: 1 filing
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13D · 2 securities · may seek to influence control
Korsana Biosciences, Inc. 13D KRSA · 23255M303	KRSA	23255M303	9.9%	4,552,277	13D	9/15/2026 Event 9/8/2026
Venrock Healthcare Capital Partners III, L.P.			9.9%	4,552,277
VHCP Co-Investment Holdings III, LLC			9.9%	4,552,277
Venrock Healthcare Capital Partners EG, L.P.			9.9%	4,552,277
Venrock Healthcare Capital Partners XP, L.P.			9.9%	4,552,277
VHCP Management III, LLC			9.9%	4,552,277
VHCP Management EG, LLC			9.9%	4,552,277
VHCP Management XP, LLC			9.9%	4,552,277
Bong Y. Koh			9.9%	4,552,277
Nimish Shah			9.9%	4,552,277
Apogee Therapeutics, Inc. 13D/A APGE · 03770N101	APGE	03770N101	0%	0	13D/A	9/8/2026 Event 9/3/2026
Venrock Healthcare Capital Partners III, L.P.			0%	0
VHCP Co-Investment Holdings III, LLC			0%	0
Venrock Healthcare Capital Partners EG, L.P.			0%	0
VHCP Management III, LLC			0%	0
VHCP Management EG, LLC			0%	0
Bong Y. Koh			0%	0
Nimish Shah			0%	0
Schedule 13G · 44 securities · passive
Entera Bio Ltd. 13G ENTX · M40527109	ENTX	M40527109	5.1%	8,861,763	13G	10/30/2026 Event 10/23/2026
Venrock Healthcare Capital Partners III, L.P.			5.1%	8,861,763
VHCP Co-Investment Holdings III, LLC			5.1%	8,861,763
Venrock Healthcare Capital Partners EG, L.P.			5.1%	8,861,763
VHCP Management III, LLC			5.1%	8,861,763
VHCP Management EG, LLC			5.1%	8,861,763
Nimish Shah			5.1%	8,861,763
Bong Y. Koh			5.1%	8,861,763
Lycia Therapeutics, Inc. 13G 55081P100		55081P100	11.9%	6,850,237	13G	10/30/2026 Event 10/23/2026
Venrock Healthcare Capital Partners III, L.P.			11.9%	6,850,237
VHCP Co-Investment Holdings III, LLC			11.9%	6,850,237
Venrock Healthcare Capital Partners EG, L.P.			11.9%	6,850,237
VHCP Management III, LLC			11.9%	6,850,237
VHCP Management EG, LLC			11.9%	6,850,237
Venrock Healthcare Capital Partners XP, L.P.			11.9%	6,850,237
VHCP Management XP, LLC			11.9%	6,850,237
Bong Y. Koh			11.9%	6,850,237
Nimish Shah			11.9%	6,850,237
Frazier Life Sciences Acquisition Corp. II 13G G37103101		G37103101	9.0%	700,000	13G	10/27/2026 Event 10/15/2026
Venrock Healthcare Capital Partners III, L.P.			9.0%	700,000
VHCP Co-Investment Holdings III, LLC			9.0%	700,000
Venrock Healthcare Capital Partners EG, L.P.			9.0%	700,000
VHCP Management III, LLC			9.0%	700,000
VHCP Management EG, LLC			9.0%	700,000
Nimish Shah			9.0%	700,000
Bong Y. Koh			9.0%	700,000
X4 Pharmaceuticals, Inc. 13G XFOR · 98420X202	XFOR	98420X202	5.6%	5,555,047	13G	9/21/2026 Event 9/14/2026
Venrock Healthcare Capital Partners III, L.P.			5.6%	5,555,047
VHCP Co-Investment Holdings III, LLC			5.6%	5,555,047
Venrock Healthcare Capital Partners EG, L.P.			5.6%	5,555,047
VHCP Management III, LLC			5.6%	5,555,047
VHCP Management EG, LLC			5.6%	5,555,047
Nimish Shah			5.6%	5,555,047
Bong Y. Koh			5.6%	5,555,047
Vor Biopharma Inc. 13G/A VOR · 929033207	VOR	929033207	9.9%	5,676,370	13G/A	8/14/2026 Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P.			9.9%	5,676,370
VHCP Co-Investment Holdings III, LLC			9.9%	5,676,370
Venrock Healthcare Capital Partners EG, L.P.			9.9%	5,676,370
VHCP Management III, LLC			9.9%	5,676,370
VHCP Management EG, LLC			9.9%	5,676,370
Nimish Shah			9.9%	5,676,370
Bong Y. Koh			9.9%	5,676,370
Tenax Therapeutics, Inc. 13G/A TENX · 88032L605	TENX	88032L605	4.7%	1,574,892	13G/A	8/14/2026 Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P.			4.7%	1,574,892
VHCP Co-Investment Holdings III, LLC			4.7%	1,574,892
Venrock Healthcare Capital Partners EG, L.P.			4.7%	1,574,892
VHCP Management III, LLC			4.7%	1,574,892
VHCP Management EG, LLC			4.7%	1,574,892
Nimish Shah			4.7%	1,574,892
Bong Y. Koh			4.7%	1,574,892
Oruka Therapeutics, Inc. 13G/A ORKA · 687604108	ORKA	687604108	7.4%	4,556,952	13G/A	8/14/2026 Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P.			7.4%	4,556,952
VHCP Co-Investment Holdings III, LLC			7.4%	4,556,952
Venrock Healthcare Capital Partners EG, L.P.			7.4%	4,556,952
VHCP Management III, LLC			7.4%	4,556,952
VHCP Management EG, LLC			7.4%	4,556,952
Nimish Shah			7.4%	4,556,952
Bong Y. Koh			7.4%	4,556,952
KalVista Pharmaceuticals, Inc. 13G/A APLT · 03828A101	APLT	03828A101	0%	0	13G/A	8/14/2026 Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P.			0%	0
VHCP Co-Investment Holdings III, LLC			0%	0
Venrock Healthcare Capital Partners EG, L.P.			0%	0
VHCP Management III, LLC			0%	0
VHCP Management EG, LLC			0%	0
Nimish Shah			0%	0
Bong Y. Koh			0%	0
Jade Biosciences, Inc. 13G/A JBIO · 008064206	JBIO	008064206	8.3%	5,145,330	13G/A	8/14/2026 Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P.			8.3%	5,145,330
VHCP Co-Investment Holdings III, LLC			8.3%	5,145,330
Venrock Healthcare Capital Partners EG, L.P.			8.3%	5,145,330
VHCP Management III, LLC			8.3%	5,145,330
VHCP Management EG, LLC			8.3%	5,145,330
Nimish Shah			8.3%	5,145,330
Bong Y. Koh			8.3%	5,145,330
enGene Holdings Inc. 13G/A ENGN · 29286M105	ENGN	29286M105	0%	0	13G/A	8/14/2026 Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P.			0%	0
VHCP Co-Investment Holdings III, LLC			0%	0
Venrock Healthcare Capital Partners EG, L.P.			0%	0
VHCP Management III, LLC			0%	0
VHCP Management EG, LLC			0%	0
Nimish Shah			0%	0
Bong Y. Koh			0%	0
Artiva Biotherapeutics, Inc. 13G/A ARTV · 04317A107	ARTV	04317A107	4.2%	2,043,596	13G/A	8/14/2026 Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P.			4.2%	2,043,596
VHCP Co-Investment Holdings III, LLC			4.2%	2,043,596
Venrock Healthcare Capital Partners EG, L.P.			4.2%	2,043,596
VHCP Management III, LLC			4.2%	2,043,596
VHCP Management EG, LLC			4.2%	2,043,596
Nimish Shah			4.2%	2,043,596
Bong Y. Koh			4.2%	2,043,596
Adlai Nortye Ltd. 13G/A ANL · 00704R109	ANL	00704R109	4.4%	9,638,193	13G/A	8/14/2026 Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P.			4.4%	9,638,193
VHCP Co-Investment Holdings III, LLC			4.4%	9,638,193
Venrock Healthcare Capital Partners EG, L.P.			4.4%	9,638,193
VHCP Management III, LLC			4.4%	9,638,193
VHCP Management EG, LLC			4.4%	9,638,193
Nimish Shah			4.4%	9,638,193
Bong Y. Koh			4.4%	9,638,193
Relmada Therapeutics, Inc. 13G RLMD · 75955J402	RLMD	75955J402	6.2%	6,508,433	13G	6/9/2026 Event 6/2/2026
Venrock Healthcare Capital Partners III, L.P.			6.2%	6,508,433
VHCP Co-Investment Holdings III, LLC			6.2%	6,508,433
Venrock Healthcare Capital Partners EG, L.P.			6.2%	6,508,433
VHCP Management III, LLC			6.2%	6,508,433
VHCP Management EG, LLC			6.2%	6,508,433
Nimish Shah			6.2%	6,508,433
Bong Y. Koh			6.2%	6,508,433
CytomX Therapeutics, Inc. 13G/A CTMX · 23284F105	CTMX	23284F105	4.6%	9,982,124	13G/A	5/15/2026 Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P.			4.6%	9,982,124
VHCP Co-Investment Holdings III, LLC			4.6%	9,982,124
Venrock Healthcare Capital Partners EG, L.P.			4.6%	9,982,124
VHCP Management III, LLC			4.6%	9,982,124
VHCP Management EG, LLC			4.6%	9,982,124
Nimish Shah			4.6%	9,982,124
Bong Y. Koh			4.6%	9,982,124
Enliven Therapeutics, Inc. 13G/A ELVN · 29337E102	ELVN	29337E102	2.8%	1,726,331	13G/A	5/15/2026 Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P.			2.8%	1,726,331
VHCP Co-Investment Holdings III, LLC			2.8%	1,726,331
Venrock Healthcare Capital Partners EG, L.P.			2.8%	1,726,331
VHCP Management III, LLC			2.8%	1,726,331
VHCP Management EG, LLC			2.8%	1,726,331
Nimish Shah			2.8%	1,726,331
Bong Y. Koh			2.8%	1,726,331
Erasca, Inc. 13G/A ERAS · 29479A108	ERAS	29479A108	5.3%	16,382,812	13G/A	5/15/2026 Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P.			5.3%	16,382,812
VHCP Co-Investment Holdings III, LLC			5.3%	16,382,812
Venrock Healthcare Capital Partners EG, L.P.			5.3%	16,382,812
VHCP Management III, LLC			5.3%	16,382,812
VHCP Management EG, LLC			5.3%	16,382,812
Nimish Shah			5.3%	16,382,812
Bong Y. Koh			5.3%	16,382,812
ORIC Pharmaceuticals, Inc. 13G/A ORIC · 68622P109	ORIC	68622P109	4.2%	4,319,765	13G/A	5/15/2026 Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P.			4.2%	4,319,765
VHCP Co-Investment Holdings III, LLC			4.2%	4,319,765
Venrock Healthcare Capital Partners EG, L.P.			4.2%	4,319,765
VHCP Management III, LLC			4.2%	4,319,765
VHCP Management EG, LLC			4.2%	4,319,765
Nimish Shah			4.2%	4,319,765
Bong Y. Koh			4.2%	4,319,765
Surrozen, Inc. 13G/A SRZN · 86889P208	SRZN	86889P208	9.9%	1,205,000	13G/A	5/15/2026 Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P.			9.9%	1,205,000
VHCP Co-Investment Holdings III, LLC			9.9%	1,205,000
Venrock Healthcare Capital Partners EG, L.P.			9.9%	1,205,000
VHCP Management III, LLC			9.9%	1,205,000
VHCP Management EG, LLC			9.9%	1,205,000
Nimish Shah			9.9%	1,205,000
Bong Y. Koh			9.9%	1,205,000
Zura Bio Limited 13G/A ZURA · G9TY5A101	ZURA	G9TY5A101	9.9%	9,816,384	13G/A	5/15/2026 Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P.			9.9%	9,816,384
VHCP Co-Investment Holdings III, LLC			9.9%	9,816,384
Venrock Healthcare Capital Partners EG, L.P.			9.9%	9,816,384
VHCP Management III, LLC			9.9%	9,816,384
VHCP Management EG, LLC			9.9%	9,816,384
Nimish Shah			9.9%	9,816,384
Bong Y. Koh			9.9%	9,816,384
Achieve Life Sciences, Inc. 13G ACHV · 004468500	ACHV	004468500	5.2%	5,502,064	13G	4/24/2026 Event 4/17/2026
Venrock Healthcare Capital Partners III, L.P.			5.2%	5,502,064
VHCP Co-Investment Holdings III, LLC			5.2%	5,502,064
Venrock Healthcare Capital Partners EG, L.P.			5.2%	5,502,064
VHCP Management III, LLC			5.2%	5,502,064
VHCP Management EG, LLC			5.2%	5,502,064
Nimish Shah			5.2%	5,502,064
Bong Y. Koh			5.2%	5,502,064
Korro Bio, Inc. 13G KRRO · 500946108	KRRO	500946108	9.9%	1,488,685	13G	3/17/2026 Event 3/10/2026
Venrock Healthcare Capital Partners III, L.P.			9.9%	1,488,685
VHCP Co-Investment Holdings III, LLC			9.9%	1,488,685
Venrock Healthcare Capital Partners EG, L.P.			9.9%	1,488,685
VHCP Management III, LLC			9.9%	1,488,685
VHCP Management EG, LLC			9.9%	1,488,685
Nimish Shah			9.9%	1,488,685
Bong Y. Koh			9.9%	1,488,685
Galecto, Inc. 13G DMRA · 36322Q206	DMRA	36322Q206	6.0%	3,603,595	13G	2/17/2026 Event 2/9/2026
Venrock Healthcare Capital Partners III, L.P.			6.0%	3,603,595
VHCP Co-Investment Holdings III, LLC			6.0%	3,603,595
Venrock Healthcare Capital Partners EG, L.P.			6.0%	3,603,595
VHCP Management III, LLC			6.0%	3,603,595
VHCP Management EG, LLC			6.0%	3,603,595
Nimish Shah			6.0%	3,603,595
Bong Y. Koh			6.0%	3,603,595
Savara Inc. 13G/A SVRA · 805111101	SVRA	805111101	9.9%	20,881,288	13G/A	2/17/2026 Event 12/31/2025
Venrock Healthcare Capital Partners III, L.P.			9.9%	20,881,288
VHCP Co-Investment Holdings III, LLC			9.9%	20,881,288
Venrock Healthcare Capital Partners EG, L.P.			9.9%	20,881,288
VHCP Management III, LLC			9.9%	20,881,288
VHCP Management EG, LLC			9.9%	20,881,288
Nimish Shah			9.9%	20,881,288
Bong Y. Koh			9.9%	20,881,288
Perceptive Capital Solutions Corp 13G/A PCSC · G70077105	PCSC	G70077105	0%	0	13G/A	2/17/2026 Event 12/31/2025
Venrock Healthcare Capital Partners III, L.P.			0%	0
VHCP Co-Investment Holdings III, LLC			0%	0
Venrock Healthcare Capital Partners EG, L.P.			0%	0
VHCP Management III, LLC			0%	0
VHCP Management EG, LLC			0%	0
Nimish Shah			0%	0
Bong Y. Koh			0%	0
Ocular Therapeutix Inc 13G/A OCUL · 67576A100	OCUL	67576A100	3.2%	6,862,972	13G/A	2/17/2026 Event 12/31/2025
Venrock Healthcare Capital Partners III, L.P.			3.2%	6,862,972
VHCP Co-Investment Holdings III, LLC			3.2%	6,862,972
Venrock Healthcare Capital Partners EG, L.P.			3.2%	6,862,972
VHCP Management III, LLC			3.2%	6,862,972
VHCP Management EG, LLC			3.2%	6,862,972
Nimish Shah			3.2%	6,862,972
Bong Y. Koh			3.2%	6,862,972
Crescent Biopharma, Inc. 13G/A CBIO · G2545C104	CBIO	G2545C104	9.5%	2,666,064	13G/A	2/17/2026 Event 12/31/2025
Venrock Healthcare Capital Partners III, L.P.			9.5%	2,666,064
VHCP Co-Investment Holdings III, LLC			9.5%	2,666,064
Venrock Healthcare Capital Partners EG, L.P.			9.5%	2,666,064
VHCP Management III, LLC			9.5%	2,666,064
VHCP Management EG, LLC			9.5%	2,666,064
Nimish Shah			9.5%	2,666,064
Bong Y. Koh			9.5%	2,666,064
CASI Pharmaceuticals, Inc. 13G/A CASIF · G1933S101	CASIF	G1933S101	9.2%	1,987,259	13G/A	2/17/2026 Event 12/31/2025
Venrock Healthcare Capital Partners III, L.P.			9.2%	1,987,259
VHCP Co-Investment Holdings III, LLC			9.2%	1,987,259
Venrock Healthcare Capital Partners EG, L.P.			9.2%	1,987,259
VHCP Management III, LLC			9.2%	1,987,259
VHCP Management EG, LLC			9.2%	1,987,259
Nimish Shah			9.2%	1,987,259
Bong Y. Koh			9.2%	1,987,259
Century Therapeutics, Inc. 13G IPSC · 15673T100	IPSC	15673T100	7.1%	13,043,478	13G	1/16/2026 Event 1/9/2026
Venrock Healthcare Capital Partners III, L.P.			7.1%	13,043,478
VHCP Co-Investment Holdings III, LLC			7.1%	13,043,478
Venrock Healthcare Capital Partners EG, L.P.			7.1%	13,043,478
VHCP Management III, LLC			7.1%	13,043,478
VHCP Management EG, LLC			7.1%	13,043,478
Nimish Shah			7.1%	13,043,478
Bong Y. Koh			7.1%	13,043,478
Abivax SA 13G/A ABVX · 00370M103	ABVX	00370M103	0.8%	576,729	13G/A	11/14/2025 Event 9/30/2025
Venrock Healthcare Capital Partners III, L.P.			0.8%	576,729
VHCP Co-Investment Holdings III, LLC			0.8%	576,729
Venrock Healthcare Capital Partners EG, L.P.			0.8%	576,729
VHCP Management III, LLC			0.8%	576,729
VHCP Management EG, LLC			0.8%	576,729
Nimish Shah			0.8%	576,729
Bong Y. Koh			0.8%	576,729
Cybin Inc. 13G HELP · 23256X407	HELP	23256X407	9.9%	5,111,412	13G	11/7/2025 Event 10/31/2025
Venrock Healthcare Capital Partners III, L.P.			9.9%	5,111,412
VHCP Co-Investment Holdings III, LLC			9.9%	5,111,412
Venrock Healthcare Capital Partners EG, L.P.			9.9%	5,111,412
VHCP Management III, LLC			9.9%	5,111,412
VHCP Management EG, LLC			9.9%	5,111,412
Nimish Shah			9.9%	5,111,412
Bong Y. Koh			9.9%	5,111,412
Cidara Therapeutics, Inc. 13G/A CDTX · 171757206	CDTX	171757206	3.2%	639,088	13G/A	8/14/2025 Event 6/30/2025
Venrock Healthcare Capital Partners III, L.P.			3.2%	639,088
VHCP Co-Investment Holdings III, LLC			3.2%	639,088
Venrock Healthcare Capital Partners EG, L.P.			3.2%	639,088
VHCP Management III, LLC			3.2%	639,088
VHCP Management EG, LLC			3.2%	639,088
Nimish Shah			3.2%	639,088
Bong Y. Koh			3.2%	639,088
Dianthus Therapeutics, Inc. 13G/A DNTH · 252828108	DNTH	252828108	3.1%	1,000,000	13G/A	8/14/2025 Event 6/30/2025
Venrock Healthcare Capital Partners III, L.P.			3.1%	1,000,000
VHCP Co-Investment Holdings III, LLC			3.1%	1,000,000
Venrock Healthcare Capital Partners EG, L.P.			3.1%	1,000,000
VHCP Management III, LLC			3.1%	1,000,000
VHCP Management EG, LLC			3.1%	1,000,000
Nimish Shah			3.1%	1,000,000
Bong Y. Koh			3.1%	1,000,000
Pharvaris N.V. 13G/A PHVS · N69605108	PHVS	N69605108	3.8%	2,047,620	13G/A	8/14/2025 Event 6/30/2025
Venrock Healthcare Capital Partners III, L.P.			3.8%	2,047,620
VHCP Co-Investment Holdings III, LLC			3.8%	2,047,620
Venrock Healthcare Capital Partners EG, L.P.			3.8%	2,047,620
VHCP Management III, LLC			3.8%	2,047,620
VHCP Management EG, LLC			3.8%	2,047,620
Nimish Shah			3.8%	2,047,620
Bong Y. Koh			3.8%	2,047,620
Tenax Therapeutics, Inc. 13G/A CDTX · 171757206	CDTX	171757206	9.9%	449,492	13G/A	8/14/2025 Event 6/30/2025
Venrock Healthcare Capital Partners III, L.P.			9.9%	449,492
VHCP Co-Investment Holdings III, LLC			9.9%	449,492
Venrock Healthcare Capital Partners EG, L.P.			9.9%	449,492
VHCP Management III, LLC			9.9%	449,492
VHCP Management EG, LLC			9.9%	449,492
Nimish Shah			9.9%	449,492
Bong Y. Koh			9.9%	449,492
Crescent Biopharma, Inc. 13G CBIO · 38000Q201 Amended under CUSIP G2545C104 on 2/17/2026	CBIO	38000Q201	9.9%	1,391,196	13G	6/23/2025 Event 6/13/2025
Venrock Healthcare Capital Partners III, L.P.			9.9%	1,391,196
VHCP Co-Investment Holdings III, LLC			9.9%	1,391,196
Venrock Healthcare Capital Partners EG, L.P.			9.9%	1,391,196
VHCP Management III, LLC			9.9%	1,391,196
VHCP Management EG, LLC			9.9%	1,391,196
Nimish Shah			9.9%	1,391,196
Bong Y. Koh			9.9%	1,391,196
Mersana Therapeutics, Inc. 13G/A MRSN · 59045L106	MRSN	59045L106	2.9%	3,574,325	13G/A	5/15/2025 Event 3/31/2025
Venrock Healthcare Capital Partners III, L.P.			2.9%	3,574,325
VHCP Co-Investment Holdings III, LLC			2.9%	3,574,325
Venrock Healthcare Capital Partners EG, L.P.			2.9%	3,574,325
VHCP Management III, LLC			2.9%	3,574,325
VHCP Management EG, LLC			2.9%	3,574,325
Nimish Shah			2.9%	3,574,325
Bong Y Koh			2.9%	3,574,325
Applied Therapeutics, Inc. 13G/A APLT · 03828A101	APLT	03828A101	4.1%	5,567,709	13G/A	5/15/2025 Event 3/31/2025
Venrock Healthcare Capital Partners III, L.P.			4.1%	5,567,709
VHCP Co-Investment Holdings III, LLC			4.1%	5,567,709
Venrock Healthcare Capital Partners EG, L.P.			4.1%	5,567,709
VHCP Management III, LLC			4.1%	5,567,709
VHCP Management EG, LLC			4.1%	5,567,709
Nimish Shah			4.1%	5,567,709
Bong Y Koh			4.1%	5,567,709
Praxis Precision Medicines, Inc. 13G/A PRAX · 74006W207	PRAX	74006W207	4.9%	1,016,497	13G/A	5/15/2025 Event 3/31/2025
Venrock Healthcare Capital Partners III, L.P.			4.9%	1,016,497
VHCP Co-Investment Holdings III, LLC			4.9%	1,016,497
Venrock Healthcare Capital Partners EG, L.P.			4.9%	1,016,497
VHCP Management III, LLC			4.9%	1,016,497
VHCP Management EG, LLC			4.9%	1,016,497
Nimish Shah			4.9%	1,016,497
Bong Y Koh			4.9%	1,016,497
4D Molecular Therapeutics, Inc. 13G/A FDMT · 35104E100	FDMT	35104E100	1.5%	677,600	13G/A	5/15/2025 Event 3/31/2025
Venrock Healthcare Capital Partners III, L.P.			1.5%	677,600
VHCP Co-Investment Holdings III, LLC			1.5%	677,600
Venrock Healthcare Capital Partners EG, L.P.			1.5%	677,600
VHCP Management III, LLC			1.5%	677,600
VHCP Management EG, LLC			1.5%	677,600
Nimish Shah			1.5%	677,600
Bong Y Koh			1.5%	677,600
Astria Therapeutics, Inc. 13G/A ATXS · 04635X102	ATXS	04635X102	4.4%	2,457,348	13G/A	2/14/2025 Event 12/31/2024
Venrock Healthcare Capital Partners III, L.P.			4.4%	2,457,348
VHCP Co-Investment Holdings III, LLC			4.4%	2,457,348
Venrock Healthcare Capital Partners EG, L.P.			4.4%	2,457,348
VHCP Management III, LLC			4.4%	2,457,348
VHCP Management EG, LLC			4.4%	2,457,348
Nimish Shah			4.4%	2,457,348
Bong Y Koh			4.4%	2,457,348
Aquestive Therapeutics, Inc. 13G/A AQST · 03843E104	AQST	03843E104	2.9%	2,629,786	13G/A	2/14/2025 Event 12/31/2024
Venrock Healthcare Capital Partners III, L.P.			2.9%	2,629,786
VHCP Co-Investment Holdings III, LLC			2.9%	2,629,786
Venrock Healthcare Capital Partners EG, L.P.			2.9%	2,629,786
VHCP Management III, LLC			2.9%	2,629,786
VHCP Management EG, LLC			2.9%	2,629,786
Nimish Shah			2.9%	2,629,786
Bong Y Koh			2.9%	2,629,786
Adverum Biotechnologies, Inc. 13G/A ADVM · 00773U207	ADVM	00773U207	0%	0	13G/A	2/14/2025 Event 12/31/2024
Venrock Healthcare Capital Partners III, L.P.			0%	0
VHCP Co-Investment Holdings III, LLC			0%	0
Venrock Healthcare Capital Partners EG, L.P.			0%	0
VHCP Management III, LLC			0%	0
VHCP Management EG, LLC			0%	0
Nimish Shah			0%	0
Bong Y Koh			0%	0
Spyre Therapeutics, Inc. 13G/A SYRE · 00773J202	SYRE	00773J202	4.6%	2,685,448	13G/A	2/14/2025 Event 12/31/2024
Venrock Healthcare Capital Partners III, L.P.			4.6%	2,685,448
VHCP Co-Investment Holdings III, LLC			4.6%	2,685,448
Venrock Healthcare Capital Partners EG, L.P.			4.6%	2,685,448
VHCP Management III, LLC			4.6%	2,685,448
VHCP Management EG, LLC			4.6%	2,685,448
Nimish Shah			4.6%	2,685,448
Bong Y Koh			4.6%	2,685,448
Viridian Therapeutics, Inc. 13G/A VRDN · 92790C104	VRDN	92790C104	4.5%	3,575,309	13G/A	2/14/2025 Event 12/31/2024
Venrock Healthcare Capital Partners III, L.P.			4.5%	3,575,309
VHCP Co-Investment Holdings III, LLC			4.5%	3,575,309
Venrock Healthcare Capital Partners EG, L.P.			4.5%	3,575,309
VHCP Management III, LLC			4.5%	3,575,309
VHCP Management EG, LLC			4.5%	3,575,309
Nimish Shah			4.5%	3,575,309
Bong Y Koh			4.5%	3,575,309

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.